Literature DB >> 22787006

Risk of myocardial infarction among patients with gout: a nationwide population-based study.

Chang-Fu Kuo1, Kuang-Hui Yu, Lai-Chu See, I-Jun Chou, Yu-Shien Ko, Hsiao-Chun Chang, Meng-Jiun Chiou, Shue-Fen Luo.   

Abstract

OBJECTIVE: To investigate the association between gout and myocardial infarction (MI) in a representative cohort in Taiwan.
METHODS: Data were collected from the Taiwan National Health Insurance database. Adults >20 years of age without history of MI were included. Patients were considered to have gout if they received a diagnosis of gout requiring medical treatment. Multivariate Cox proportional hazards models were used to evaluate the risk of MI in gout patients.
RESULTS: Of the 704 503 patients included, 26 556 (3.8%) had gout. In total, 3718 (with gout, n = 463; without gout, n = 3255) patients had an MI, 299 (with gout, n = 35; without gout, n = 264) of whom died. The incidence of MI was 2.20 and 0.60 per 1000 patient-years in individuals with and without gout, respectively (log-rank test, P < 0.001). After adjustment for age, sex and history of diabetes mellitus, hypertension, coronary heart disease (CHD), stroke and end-stage renal disease, gout was associated with MIs [hazard ratio (HR), 1.23] and non-fatal MIs (HR, 1.26). In individuals without cardiovascular risk factors, gout was associated with MIs (HR 1.84; 95% CI 1.51, 2.24) and non-fatal MIs (HR 1.80; 95% CI 1.49, 3.95), after adjustment for age and sex. Moreover, in our study population, the HRs for MI decreased as age increased.
CONCLUSION: Gout is an independent risk factor for MI, and the increased risk of MI is present even in young people and those without cardiovascular risk factors.

Entities:  

Mesh:

Year:  2012        PMID: 22787006     DOI: 10.1093/rheumatology/kes169

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  40 in total

1.  Acute gouty arthritis complicated with acute ST elevation myocardial infarction is independently associated with short- and long-term adverse non-fatal cardiac events.

Authors:  Kuan-Liang Liu; Hsin-Fu Lee; Shing-Hsien Chou; Yen-Chen Lin; Chia-Pin Lin; Chun-Li Wang; Chi-Jen Chang; Lung-An Hsu
Journal:  Clin Rheumatol       Date:  2013-08-30       Impact factor: 2.980

2.  As compared to allopurinol, urate-lowering therapy with febuxostat has superior effects on oxidative stress and pulse wave velocity in patients with severe chronic tophaceous gout.

Authors:  A-K Tausche; M Christoph; M Forkmann; U Richter; S Kopprasch; C Bielitz; M Aringer; C Wunderlich
Journal:  Rheumatol Int       Date:  2013-09-12       Impact factor: 2.631

Review 3.  Global epidemiology of gout: prevalence, incidence and risk factors.

Authors:  Chang-Fu Kuo; Matthew J Grainge; Weiya Zhang; Michael Doherty
Journal:  Nat Rev Rheumatol       Date:  2015-07-07       Impact factor: 20.543

4.  Long-term risk of coronary events after AKI.

Authors:  Vin-Cent Wu; Che-Hsiung Wu; Tao-Min Huang; Cheng-Yi Wang; Chun-Fu Lai; Chih-Chung Shiao; Chia-Hsui Chang; Shuei-Liong Lin; Yen-Yuan Chen; Yung-Ming Chen; Tzong-Shinn Chu; Wen-Chih Chiang; Kwan-Dun Wu; Pi-Ru Tsai; Likwang Chen; Wen-Je Ko
Journal:  J Am Soc Nephrol       Date:  2014-02-06       Impact factor: 10.121

Review 5.  Update on colchicine, 2017.

Authors:  Anastasia Slobodnick; Binita Shah; Svetlana Krasnokutsky; Michael H Pillinger
Journal:  Rheumatology (Oxford)       Date:  2018-01-01       Impact factor: 7.580

Review 6.  [Full version of the S2e guidelines on gouty arthritis : Evidence-based guidelines of the German Society of Rheumatology (DGRh)].

Authors:  U Kiltz; R Alten; M Fleck; K Krüger; B Manger; U Müller-Ladner; H Nüßlein; M Reuss-Borst; A Schwarting; H Schulze-Koops; A Tausche; J Braun
Journal:  Z Rheumatol       Date:  2016-08       Impact factor: 1.372

7.  Value of three-dimensional speckle tracking echocardiography to assess left ventricular function in hyperuricemia patients.

Authors:  Xiaojie Zhang; Qing Lu; Zhuojun Zhang; Yongle Chen; Yanan Wang; Youngshi Wang; Zheng Li; Lindi Jiang
Journal:  Clin Rheumatol       Date:  2018-05-22       Impact factor: 2.980

Review 8.  Hyperuricemia, gout, and cardiovascular disease: an update.

Authors:  Aryeh M Abeles
Journal:  Curr Rheumatol Rep       Date:  2015-03       Impact factor: 4.592

Review 9.  Optimizing current treatment of gout.

Authors:  Frances Rees; Michelle Hui; Michael Doherty
Journal:  Nat Rev Rheumatol       Date:  2014-03-11       Impact factor: 20.543

10.  Clinical characteristics associated with subcutaneous tophi formation in Chinese gout patients: a retrospective study.

Authors:  Lidan Ma; Ruixia Sun; Zhaotong Jia; Yaowu Zou; Ying Xin; Xiaoyu Cheng; Tian Liu; Lingling Cui; Zhen Liu; Xinjiang Wu; Changgui Li
Journal:  Clin Rheumatol       Date:  2018-01-22       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.